Neurocrine Bioscience buy Oppenheimer Holdings Inc.
Start price
18.03.24
/
50%
€128.35
Target price
18.03.25
€183.92
Performance (%)
-1.01%
Price
26.04.24
€127.05
Summary
This prediction is currently active. With a performance of -1.01%, the BUY prediction by Oppenheimer_Holdings is trending in the wrong direction. This prediction currently runs until 18.03.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 2.542% | 2.542% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Oppenheimer Holdings Inc. from $170.00 to $200.00. They now have an "outperform" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€134.95
24.04.24
24.04.24
€187.12
24.04.25
24.04.25
-5.85%
26.04.24
26.04.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€94.60
02.08.23
02.08.23
€137.10
02.08.24
02.08.24
34.30%
26.04.24
26.04.24